These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 26648244)

  • 21. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
    Chen D; Li Y; Yu Z; Li Y; Su Z; Ni L; Yang S; Gui Y; Lai Y
    Mol Med Rep; 2015 Aug; 12(2):3061-6. PubMed ID: 25936999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Jin L; Li Y; Liu J; Yang S; Gui Y; Mao X; Nie G; Lai Y
    Mol Med Rep; 2016 Jun; 13(6):5386-92. PubMed ID: 27121091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
    Lai Y; Zhao L; Hu J; Quan J; Chen P; Xu J; Guan X; Lai Y; Ni L
    Mol Med Rep; 2018 Jun; 17(6):8510-8517. PubMed ID: 29693121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
    Zhu S; Huang Y; Su X
    Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-21 functions as an oncogene and promotes cell proliferation and invasion via TIMP3 in renal cancer.
    Chen J; Gu Y; Shen W
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4566-4576. PubMed ID: 29131259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
    Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
    Zhang WB; Pan ZQ; Yang QS; Zheng XM
    Ir J Med Sci; 2013 Dec; 182(4):621-7. PubMed ID: 23619562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressive microRNA‑429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma.
    Chen D; Li Y; Li Y; Jin L; Su Z; Yu Z; Yang S; Mao X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1361-6. PubMed ID: 26647818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
    Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
    J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.